ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Adds Georgetown, MSK to Program

May 1, 1981

ASCO, AACR Hold Last Joint annual Meeting, Vow to Encourage Basic-Clinical Interaction

May 28, 1993

From Long Island To Houston By Rental Care, In 43 Hours.

October 5, 2001

Varmus Discusses Grant Policy, Changes in Congress and Ebola

December 12, 2014

St. Jude Considers Relocating to Washington U.

August 9, 1985

In Brief: OSCC Staff Appointments Announced Report Available On Chemical Disposal Health Aspects

August 3, 1984